Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

A protease-activatable luminescent biosensor and reporter cell line for authentic SARS-CoV-2 infection
Pehuén Pereyra Gerber, Lidia M. Duncan, Edward JD Greenwood, et al.
PLoS Pathogens (2022) Vol. 18, Iss. 2, pp. e1010265-e1010265
Open Access | Times Cited: 34

Showing 1-25 of 34 citing articles:

Altered TMPRSS2 usage by SARS-CoV-2 Omicron impacts infectivity and fusogenicity
Bo Meng, Adam Abdullahi, Isabella A. T. M. Ferreira, et al.
Nature (2022) Vol. 603, Iss. 7902, pp. 706-714
Open Access | Times Cited: 956
FXR inhibition may protect from SARS-CoV-2 infection by reducing ACE2
Teresa Brevini, Mailis Maes, Gwilym J. Webb, et al.
Nature (2022) Vol. 615, Iss. 7950, pp. 134-142
Open Access | Times Cited: 223
Progress and Challenges in Targeting the SARS-CoV-2 Papain-like Protease
Haozhou Tan, Yanmei Hu, Prakash D. Jadhav, et al.
Journal of Medicinal Chemistry (2022) Vol. 65, Iss. 11, pp. 7561-7580
Open Access | Times Cited: 115
Accelerated waning of the humoral response to COVID-19 vaccines in obesity
Agatha A. van der Klaauw, Emily C. Horner, Pehuén Pereyra-Gerber, et al.
Nature Medicine (2023) Vol. 29, Iss. 5, pp. 1146-1154
Open Access | Times Cited: 53
SARS-CoV-2 Omicron spike mediated immune escape and tropism shift
Ravindra K. Gupta
Research Square (Research Square) (2022)
Open Access | Times Cited: 47
Age-associated B cells predict impaired humoral immunity after COVID-19 vaccination in patients receiving immune checkpoint blockade
Juan Carlos Yam‐Puc, Zhaleh Hosseini, Emily C. Horner, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 19
LRRC15 mediates an accessory interaction with the SARS-CoV-2 spike protein
Jarrod Shilts, Thomas W.M. Crozier, Ana Teixeira-Silva, et al.
PLoS Biology (2023) Vol. 21, Iss. 2, pp. e3001959-e3001959
Open Access | Times Cited: 16
Development of Novel Antivrial Agents That Induce the Degradation of the Main Protease of Human-infecting Coronaviruses
Shuihong Cheng, Yong Feng, Wei Li, et al.
European Journal of Medicinal Chemistry (2024) Vol. 275, pp. 116629-116629
Closed Access | Times Cited: 5
Enhanced Selectivity in Detecting Matrix Metalloproteinase-2 Via Sequential Affinity Capture, Cascade Reaction, and Electrochemical Measurement
Seonhwa Park, Minji Gwon, Hyeryeong Lee, et al.
(2025)
Closed Access
Individual patient and donor seroprofiles in convalescent plasma treatment of COVID-19 in REMAP-CAP clinical trial
Visa Nurmi, Richard Mayne, Chanice Knight, et al.
Journal of Infection (2025), pp. 106412-106412
Closed Access
Tea Catechins in Green Tea Inhibit the Activity of SARS-CoV-2 Main Protease via Covalent Adduction
Yoji Kato, Sakiko Suzuki, Akari Higashiyama, et al.
Journal of Agricultural and Food Chemistry (2025)
Closed Access
Enhanced selectivity in detecting matrix metalloproteinase-2 via sequential affinity capture, cascade reaction, and electrochemical measurement
Seonhwa Park, Minji Gwon, Hyeryeong Lee, et al.
Sensors and Actuators B Chemical (2025), pp. 137586-137586
Closed Access
Gain-of-Signal Assays for Probing Inhibition of SARS-CoV-2 M pro /3CL pro in Living Cells
Seyed Arad Moghadasi, Morgan A. Esler, Yuka Otsuka, et al.
mBio (2022) Vol. 13, Iss. 3
Open Access | Times Cited: 26
Proteases, a powerful biochemical tool in the service of medicine, clinical and pharmaceutical
Ghadir A. Jamal, Ehsan Jahangirian, Michael R. Hamblin, et al.
Preparative Biochemistry & Biotechnology (2024) Vol. 55, Iss. 1, pp. 1-25
Closed Access | Times Cited: 4
Attenuated humoral responses in HIV after SARS-CoV-2 vaccination linked to B cell defects and altered immune profiles
Emma Touizer, Aljawharah Alrubayyi, Rosemarie Ford, et al.
iScience (2022) Vol. 26, Iss. 1, pp. 105862-105862
Open Access | Times Cited: 18
Duplex Electrochemical Microfluidic Sensor for COVID‐19 Antibody Detection: Natural versus Vaccine‐Induced Humoral Response
Vincenzo Mazzaracchio, Mauricio Rios Maciel, Tatiana Porto Santos, et al.
Small (2023) Vol. 19, Iss. 51
Open Access | Times Cited: 11
Stability of gut microbiome after COVID-19 vaccination in healthy and immuno-compromised individuals
Rebecca H. Boston, Rui Guan, Lajos Kalmár, et al.
Life Science Alliance (2024) Vol. 7, Iss. 4, pp. e202302529-e202302529
Open Access | Times Cited: 3
Rapid discovery of monoclonal antibodies by microfluidics-enabled FACS of single pathogen-specific antibody-secreting cells
Katrin Fischer, Aleksei Lulla, Tsz Y. So, et al.
Nature Biotechnology (2024)
Open Access | Times Cited: 3
Advancements in Testing Strategies for COVID-19
Rabia Asghar, Madiha Rasheed, Jalees Ul Hassan, et al.
Biosensors (2022) Vol. 12, Iss. 6, pp. 410-410
Open Access | Times Cited: 16
Bioengineered small extracellular vesicles deliver multiple SARS‐CoV‐2 antigenic fragments and drive a broad immunological response
Hannah K Jackson, Heather M. Long, Juan Carlos Yam‐Puc, et al.
Journal of Extracellular Vesicles (2024) Vol. 13, Iss. 2
Open Access | Times Cited: 2
XNAzymes targeting the SARS-CoV-2 genome inhibit viral infection
Pehuén Pereyra Gerber, Maria J. Donde, Nicholas J. Matheson, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 11
Food phytochemicals, epigallocatechin gallate and myricetin, covalently bind to the active site of the coronavirus main protease in vitro
Yoji Kato, Akari Higashiyama, Emi Takaoka, et al.
Advances in Redox Research (2021) Vol. 3, pp. 100021-100021
Open Access | Times Cited: 15
Proteolytic Biosensors with Functional Nanomaterials: Current Approaches and Future Challenges
Jin‐Ha Choi
Biosensors (2023) Vol. 13, Iss. 2, pp. 171-171
Open Access | Times Cited: 5
Design and synthesis of isatin derivatives as effective SARS‐CoV‐2 3CL protease inhibitors
Hong‐Lei Bao, Gao Tu, Yue Qiu, et al.
Chemical Biology & Drug Design (2023) Vol. 102, Iss. 4, pp. 857-869
Closed Access | Times Cited: 4
Studies on the selectivity of the SARS-CoV-2 papain-like protease reveal the importance of the P2′ proline of the viral polyprotein
H. T. Henry Chan, Lennart Brewitz, Petra Lukacik, et al.
RSC Chemical Biology (2023) Vol. 5, Iss. 2, pp. 117-130
Open Access | Times Cited: 3
Page 1 - Next Page

Scroll to top